NCT02648230

Brief Summary

The model by which physicians measure the lack of blood flow in the vessels that supply blood to the heart muscle is called Fractional Flow Reserve (FFR). FFR is the measurement of the pressure across the vessels that supply blood to the heart. These are known as the coronary arteries. This study involves comparing two FFR wires, the St. Jude Medical Pressure Wire (PW) and the ACIST Navvus Microcatheter (MC) to check the accuracy of the devices. FFR allows real-time estimation of the effects of a narrowed vessel, whereas standard angiography can underestimate or overestimate narrowing, because it only visualizes contrast (the different areas of color) inside a vessel.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

December 23, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 6, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2016

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

June 14, 2019

Completed
Last Updated

June 14, 2019

Status Verified

June 1, 2019

Enrollment Period

1 year

First QC Date

December 23, 2015

Results QC Date

March 29, 2019

Last Update Submit

June 13, 2019

Conditions

Keywords

IschemiaFractional Flow ReserveStent

Outcome Measures

Primary Outcomes (1)

  • Mean Fractional Flow Reserve (FFR)

    The mean FFR will be measured with the pressure catheter (PC) to be compared against the mean FFR measured with a standard Pressure Wire (PW) within the same subject across the same target lesion at the same time. Fractional flow reserve measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery.

    Through study completion (an average of an hour)

Study Arms (1)

Pressure wire and Microcatheter

EXPERIMENTAL

All subjects enrolled will have both an FFR done measured by a pressure wire (PW) and then again by a microcatheter (MC).

Device: St. Jude Medical Pressure WireDevice: ACIST Navvus Microcatheter

Interventions

FFR measurement will be obtained with a PW with the FFR measurement obtained by using a MC within the same subject across the same target lesion at the same time

Also known as: PW
Pressure wire and Microcatheter

FFR measurement will be obtained with a MC with the FFR measurement obtained by using a PW within the same subject across the same target lesion at the same time

Also known as: MC
Pressure wire and Microcatheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Patient provides signed written informed consent before any study-specific procedure.
  • Undergoing coronary angiography, for silent ischemia, stable angina, acute coronary syndrome, or other acceptable indication per the local standard of care.
  • Angiographically significant (\>50% visual estimation) stenosis present in at least one native coronary artery.
  • Undergoing FFR assessment for standard clinical or diagnostic indications

You may not qualify if:

  • Aorto-ostial lesion location within 3 mm of the aorta junction (both right and left).
  • Vessel(s) and lesion(s) not amenable for PCI, for example diffuse disease.
  • Currently participating in another clinical study that interferes with study results.
  • Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 year following index procedure.
  • Any other medical condition that in the opinion of the investigator will interfere with patient safety or study results.
  • High degree A-V block, sinus node disease.
  • Known hypersensitivity to adenosine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

IschemiaAngina Pectoris

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and Symptoms

Results Point of Contact

Title
Ajay Kirtane, MD, SM
Organization
Columbia University

Study Officials

  • Ajay Kirtane, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

December 23, 2015

First Posted

January 6, 2016

Study Start

December 1, 2015

Primary Completion

December 8, 2016

Study Completion

December 8, 2016

Last Updated

June 14, 2019

Results First Posted

June 14, 2019

Record last verified: 2019-06

Locations